Position in KRYS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$176,929,041
+$55,779,546 QoQ
Shares Held
476,038
+1.5% QoQ
Ownership
1.61%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 416 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 89%
Shared 6%
None 5%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,102,677,105 across 230 Biotechnology names. KRYS ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
This page
|
476,038 | $176,929,041 |
All Filings in KRYS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,929,041 | 476,038 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $121,149,495 | 468,990 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $121,536,328 | 492,968 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $94,260,663 | 533,964 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $69,539,499 | 505,889 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $96,265,593 | 533,919 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $92,209,918 | 588,599 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $109,265,508 | 600,261 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $106,594,202 | 580,452 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $101,938,764 | 572,915 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $68,332,991 | 550,806 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $60,393,892 | 520,637 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $57,126,486 | 486,597 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $36,994,923 | 462,090 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $30,839,155 | 389,285 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $25,010,936 | 358,837 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $18,117,103 | 275,923 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $17,464,288 | 262,463 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,537,337 | 150,641 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $8,555,339 | 163,864 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $14,532,416 | 213,712 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $11,196,377 | 145,332 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,100,640 | 68,344 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $2,021,369 | 46,954 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,485,238 | 35,858 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||